Production (Stage)
BioStem Technologies, Inc.
BSEM
$11.98
-$0.0225-0.19%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 12.44M | 4.09M | 5.27M | -3.88M |
| Total Depreciation and Amortization | -- | 256.70K | 213.40K | 215.20K | 223.30K |
| Total Amortization of Deferred Charges | -- | 377.30K | 275.10K | 275.10K | 249.20K |
| Total Other Non-Cash Items | -- | 7.48M | 11.25M | 11.25M | 8.40M |
| Change in Net Operating Assets | -- | -5.65M | -10.77M | -11.95M | -7.26M |
| Cash from Operations | -- | 14.90M | 5.05M | 5.06M | -2.27M |
| Capital Expenditure | -- | -295.20K | -268.70K | -268.70K | -57.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -105.00K | -105.00K | -105.00K | -105.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1.15M | 105.00K | 105.00K | 105.30K |
| Cash from Investing | -- | -1.55M | -268.70K | -268.70K | -57.60K |
| Total Debt Issued | -- | 60.90K | 549.40K | 549.40K | 1.63M |
| Total Debt Repaid | -- | -1.20M | -1.34M | -1.35M | -1.23M |
| Issuance of Common Stock | -- | 2.29M | 2.26M | 2.26M | 2.42M |
| Repurchase of Common Stock | -- | 0.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1.15M | 1.46M | 1.46M | 2.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -- | 14.50M | 6.25M | 6.25M | 494.50K |